Opportunity radar
4,186,134 patents indexed · 165,974,948 citations · issued 2005-01-04 → 2026-05-05
Showing50 of 77,862
Pharma (A61K)Therapy methods (A61P)Med devices (A61M)Agriculture (A01)Hand tools (B25)Consumer (A47)Energy (H01M)AI / ML (G06N)
| Patent # | Title | Assets | Issued | Expires | Fwd cites | Score |
|---|---|---|---|---|---|---|
| 12611427 | Treatment of NSCLC patients refractory for anti-PD-1 antibody | 🖼🧊📄§ | 2026-04-28 | 2039-11-04 | 0 | 31 |
| 12612406 | Cytisine salts | 🖼🧊📄§ | 2026-04-28 | 2042-07-29 | 0 | 31 |
| 12611424 | Cosmetic/dermatological composition | 🖼🧊📄§ | 2026-04-28 | 2039-12-30 | 0 | 31 |
| 12611383 | Pharmaceutical compositions for treating MCT8 deficiency | 🖼🧊📄§ | 2026-04-28 | 2045-07-07 | 0 | 31 |
| 12612429 | Derivatives of dolaproine-dolaisoleuine peptides | 🖼🧊📄§ | 2026-04-28 | 2042-03-18 | 0 | 31 |
| 12611455 | DNA nanostructure-based vaccines | 🖼🧊📄§ | 2026-04-28 | 2040-06-05 | 0 | 31 |
| 12611405 | Agent that increases the expression of the BCL2-associated agonist of cell death for the treatment of cancer | 🖼🧊📄§ | 2026-04-28 | 2038-03-28 | 0 | 31 |
| 12611441 | PSMA specific binding proteins for cancer diagnosis and treatment | 🖼🧊📄§ | 2026-04-28 | 2040-04-08 | 0 | 31 |
| 12612431 | Cyclic compounds for treating cancer | 🖼🧊📄§ | 2026-04-28 | 2042-06-10 | 0 | 31 |
| 12612457 | Humanized antibodies against Nectin-2 and drug conjugates thereof | 🖼🧊📄§ | 2026-04-28 | 2044-08-28 | 0 | 31 |
| 12612597 | Methods for preparing therapeutically active cells using microfluidics | 🖼🧊📄§ | 2026-04-28 | 2041-09-06 | 0 | 31 |
| 12612438 | Bistable type II opsins and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2041-09-19 | 0 | 31 |
| 12611425 | Compositions and methods for treatment and prevention of pathogens | 🖼🧊📄§ | 2026-04-28 | 2043-08-14 | 0 | 31 |
| 12612635 | BCMA-binding single variable structural domain and antigen-binding molecule | 🖼🧊📄§ | 2026-04-28 | 2041-08-16 | 0 | 31 |
| 12612444 | T cell receptors targeting mutations in RNA splicing factors | 🖼🧊📄§ | 2026-04-28 | 2040-11-25 | 0 | 31 |
| 12611374 | Dermatological collar for non-human animals | 🖼🧊📄§ | 2026-04-28 | 2042-03-09 | 0 | 31 |
| 12611429 | Processes for production of tumor infiltrating lymphocytes and uses of same in immunotherapy | 🖼🧊📄§ | 2026-04-28 | 2042-08-03 | 0 | 31 |
| 12611401 | Combinations comprising benzodioxol as GLP-1R agonists for use in the treatment of NASH/NAFLD and related diseases | 🖼🧊📄§ | 2026-04-28 | 2040-05-15 | 0 | 31 |
| 12611438 | Antiviral composition comprising a nucleolin-binding peptide | 🖼🧊📄§ | 2026-04-28 | 2042-05-18 | 0 | 31 |
| 12611413 | Pharmaceutical compositions comprising meloxicam | 🖼🧊📄§ | 2026-04-28 | 2045-07-08 | 0 | 31 |
| 12611434 | Bifidobacterium brevis and its application in preventing or alleviating psoriasis thereof | 🖼🧊📄§ | 2026-04-28 | 2043-06-21 | 0 | 31 |
| 12611445 | Interleukin-2 variants with modified biological activity | 🖼🧊📄§ | 2026-04-28 | 2040-03-27 | 0 | 31 |
| 12611448 | Targeting delivery system loaded with whole-cell components and use thereof | 🖼🧊📄§ | 2026-04-28 | 2040-11-05 | 0 | 31 |
| 12611421 | Hydroxypropyl beta-cyclodextrin compositions and methods | 🖼🧊📄§ | 2026-04-28 | 2043-12-08 | 0 | 31 |
| 12611367 | Anti-pollution composite powder having UV- and fine dust-blocking function and cosmetic composition comprising same | 🖼🧊📄§ | 2026-04-28 | 2041-03-31 | 0 | 31 |
| 12611396 | Microsphere-based injectible celecoxib formulation | 🖼🧊📄§ | 2026-04-28 | 2040-08-06 | 0 | 31 |
| 12611392 | Mitochondria-targeting antioxidants | 🖼🧊📄§ | 2026-04-28 | 2040-11-06 | 0 | 31 |
| 12611391 | Materials and methods for improving lung function and for prevention and/or treatment of radiation-induced lung complications | 🖼🧊📄§ | 2026-04-28 | 2042-11-22 | 0 | 31 |
| 12611368 | Dry compositions and/or emulsions for chemical and physical sun protection and use thereof | 🖼🧊📄§ | 2026-04-28 | 2041-05-03 | 0 | 31 |
| 12611422 | Hydroxypropyl beta-cyclodextrin compositions and methods | 🖼🧊📄§ | 2026-04-28 | 2045-10-06 | 0 | 31 |
| 12611642 | Adapter and method of mixing constituents of a pharmaceutical complex via an adapter | 🖼🧊📄§ | 2026-04-28 | 2042-10-04 | 0 | 31 |
| 12612611 | Tetrahedral antibodies | 🖼🧊📄§ | 2026-04-28 | 2041-07-12 | 0 | 31 |
| 12612645 | AAV vectors encoding mini-PCDH15 and uses thereof | 🖼🧊📄§ | 2026-04-28 | 2040-04-24 | 0 | 31 |
| 12611469 | Promoter specific for non-pigmented ciliary epithelial cells | 🖼🧊📄§ | 2026-04-28 | 2040-09-24 | 0 | 31 |
| 12611288 | Dental implant, component for dental applications, implant system for dental applications, method for forming a protective layer on the surface of an implantable or implant component, implantable or implant component having a protective layer, and use of a protective layer | 🖼🧊📄§ | 2026-04-28 | 2042-01-05 | 0 | 31 |
| 12611376 | Drug delivering stretch ring | 🖼🧊📄§ | 2026-04-28 | 2043-10-27 | 0 | 31 |
| 12612626 | siRNA compound that inhibits expression of APOC3 | 🖼🧊📄§ | 2026-04-28 | 2042-06-24 | 0 | 31 |
| 12612402 | Nitrogen-containing fused heterocyclic compounds of n-sulfonamide and use thereof | 🖼🧊📄§ | 2026-04-28 | 2045-01-17 | 0 | 31 |
| 12611291 | Biosensor performance indicator systems for orthodontic appliances | 🖼🧊📄§ | 2026-04-28 | 2043-01-12 | 0 | 31 |
| 12611492 | Local drug delivery devices and methods for treating cancer | 🖼🧊📄§ | 2026-04-28 | 2044-03-29 | 0 | 31 |
| 12611468 | Recombinant adeno-associated virus vectors to target medullary thyroid carcinoma | 🖼🧊📄§ | 2026-04-28 | 2042-02-01 | 0 | 31 |
| 12611471 | Composite ferrite nanoparticle with synergistic enhancement of liver specificity and preparation method and application thereof | 🖼🧊📄§ | 2026-04-28 | 2041-02-01 | 0 | 31 |
| 12611461 | Bioorthogonal compositions | 🖼🧊📄§ | 2026-04-28 | 2045-04-16 | 0 | 31 |
| 12611462 | Compounds and compositions including phosphorothioated oligodeoxynucleotide, and methods of use thereof | 🖼🧊📄§ | 2026-04-28 | 2042-07-14 | 0 | 31 |
| 12612427 | Aryl glucoside derivative, preparation method therefor and application thereof | 🖼🧊📄§ | 2026-04-28 | 2040-11-24 | 0 | 31 |
| 12612464 | Autoantibody specifically binding to NELL-1 and elevated NELL-1 polypeptide levels for identifying and treating membranous nephropathy | 🖼🧊📄§ | 2026-04-28 | 2040-09-18 | 0 | 31 |
| 12612598 | Enhanced expansion of tumor-infiltrating lymphocytes for adoptive cell therapy | 🖼🧊📄§ | 2026-04-28 | 2042-06-28 | 0 | 31 |
| 12612364 | Salts and solid forms of 4-hydroxy-N,N-diisopropyltryptamine hemi-glutarate and hemi-succinate | 🖼🧊📄§ | 2026-04-28 | 2045-12-03 | 0 | 31 |
| 12612450 | Anti-pneumococcal hyperimmune globulin for the treatment and prevention of pneumococcal infection | 🖼🧊📄§ | 2026-04-28 | 2044-02-12 | 0 | 31 |
| 12612453 | Method of treating glomerulonephritis by administering an antibody which binds and neutralizes human TGF-Beta1, TGF-Beta2 and TGF-Beta3 | 🖼🧊📄§ | 2026-04-28 | 2042-09-16 | 0 | 31 |